Table 2.
Association of the metabolic syndrome at phase 3 with the onset of depressive symptoms between phases 3 (1991–1993) and 5 (1997–1999)
| n; n with new-onset depressive symptons | OR (95% CI) | P | |
|---|---|---|---|
| Metabolic syndrome | 5,232; 428 | ||
| Model 1 | 1.47 (1.09–1.99) | 0.01 | |
| Model 2 | 1.38 (1.02–1.87) | 0.04 | |
| Central obesity | 5,182; 424 | ||
| Model 1 | 1.50 (1.11–2.01) | 0.007 | |
| Model 2 | 1.42 (1.06–1.91) | 0.02 | |
| High triglycerides | 5,232; 428 | ||
| Model 1 | 1.36 (1.09–1.71) | 0.007 | |
| Model 2 | 1.30 (1.03–1.63) | 0.02 | |
| Low HDL cholesterol | 5,232; 428 | ||
| Model 1 | 1.33 (1.04–1.69) | 0.02 | |
| Model 2 | 1.26 (0.98–1.61) | 0.07 | |
| Hypertension | 5,232; 428 | ||
| Model 1 | 1.06 (0.86–1.31) | 0.57 | |
| Model 2 | 1.05 (0.85–1.30) | 0.66 | |
| High FBG | 5,049; 406 | ||
| Model 1 | 0.58 (0.33–1.04) | 0.07 | |
| Model 2 | 0.57 (0.32–1.02) | 0.06 |
Results of logistic regression analyses expressed as OR (95% CI). Model 1 is adjusted for sex, age at phase 3, and ethnicity. Model 2 reflects model 1 additionally adjusted for education, employment grade, marital status, smoking habits, alcohol consumption, physical activity, and CHD.